The project aims to develop a new drug for the treatment of cancer based on the effectiveness of natural anti-leukemic mechanisms of NK cells (Natural Killers). The use of NK cells is now a major alternative for the treatment of tumour pathologies. The project also explores NK cell applications with Mab (monoclonal antibodies).